M&A Deal Summary

Heska Acquires LightDeck Diagnostics

On September 12, 2022, Heska acquired life science company LightDeck Diagnostics for 39M USD

Acquisition Highlights
  • This is Heska’s 2nd transaction in the Life Science sector.
  • This is Heska’s largest (disclosed) transaction.
  • This is Heska’s 5th transaction in the United States.
  • This is Heska’s 4th transaction in Colorado.

M&A Deal Summary
Date 2022-09-12
Target LightDeck Diagnostics
Sector Life Science
Buyer(s) Heska
Deal Type Add-on Acquisition
Deal Value 39M USD

Target

LightDeck Diagnostics

Boulder, Colorado, United States
LightDeck Diagnostics provides innovative planar waveguide fluorescence immunoassay diagnostics with strong manufacturing and specialized production capabilities. The company has developed a scalable and innovative platform for rapid and accurate point-of-care diagnostics. LightDeck's 80-member team includes industry veterans, engineers, and scientists, with deep technical expertise in assay development, manufacturing, and software development, who has collaborated with commercial, academic, and government partners worldwide to build an extensive intellectual property portfolio of 16 US patents and 15 international patents with broad applications, including in veterinary diagnostics, water testing, and human in-vitro diagnostics use. Its planar waveguide technology optimizes laser-activated fluorescence and microfluidics to provide point-of-care cartridge-based testing without compromise, enabling reference lab-quality results in minutes with inexpensive, quantitative, and easy-to-use functionality. LightDeck was formed in 2009 and is based in Boulder, Colorado.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Heska

Loveland, Colorado, United States
Category Company
Founded 1988
Sector Medical Products
Employees808
Revenue 257M USD (2022)
DESCRIPTION

Heska sells, manufactures, markets, and supports diagnostic and specialty products and solutions for veterinary practitioners. The company's portfolio includes point-of-care diagnostic laboratory instruments and consumables including rapid assay diagnostic products and digital cytology services; local and cloud-based data services; practice information management software (“PIMS”) and related software and support; reference laboratory testing; allergy testing and immunotherapy; heartworm preventive products; and vaccines. Heska’s primary focus is supporting companion animal veterinarians in providing care to their patients. Its business is composed of two operating and reportable segments: North America and International. North America consists of the United States, Canada, and Mexico. International consists of geographies outside of North America, primarily in Germany, Italy, Spain, France, Switzerland, Australia and Malaysia. Heska’s strategic focus on point-of-care diagnostic laboratory products is included in both segments. The North America segment also includes the contract manufacturing of vaccines and pharmaceutical products and a small veterinary laboratory, and the international segment includes PIMS business and veterinary laboratories. Heska was founded in 1988 and is based in Loveland, Colorado.

DEAL STATS #
Overall 8 of 8
Sector (Life Science) 2 of 2
Type (Add-on Acquisition) 6 of 6
State (Colorado) 4 of 4
Country (United States) 5 of 5
Year (2022) 1 of 1
Size (of disclosed) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-11-02 VetZ

Isernhagen, Germany

VetZ is a provider of veterinary practice information management software solutions ("PIMS"). VetZ offers easy-to-use and fully integrated software solutions for better workflow, communication, service and patient outcomes. VetZ was founded in 1997 and headquartered in Isernhagen, Germany.

Buy -
Mergr

Product

Company

Legal